Search | La Lingua Nostra

added article Health

2026-03-18 10:12:05 -

Gastrointestinal Therapeutics Market: How Is GERD Pharmacotherapy Evolving Beyond PPIs?

Gastroesophageal reflux disease pharmacotherapy is evolving beyond the proton pump inhibitor standard that has dominated management for three decades, with the Gastrointestinal Therapeutics Market reflecting the emergence of potassium-competitive acid blockers, reflux inhibitors, and bile acid binding therapy that address the limitations of PPI therapy for patients with ongoing symptoms despite...

0 Comments 0 Shares 7 Views 0 Reviews